Lobbying Relationship

Client

Compressed Gas Association, Inc.

More records

Lobbying firm

Compressed Gas Association, Inc.

More records

  • Regulation of medical gas product manufacturing and cylinders; implementation of medical gas provisions in Public Law 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of medical gas provisions in Public Law 115-31, the Consolidated Appropriations Act of 2017; medical gas provisions in the FY 2025 appropriations to the Food and Drug Administration; FDA proposed rulemaking on Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases.
  • Safe production and reliable supply of helium; sale of the Federal Helium Reserve in Amarillo, Texas; helium supply chain issues; carbon dioxide supply chain and life cycle assessment issues; implementation of Public Law No: 117-169, the Inflation Reduction Act section 45Q regarding CO2 sequestration; Carbon Capture Utilization Parity Act of 2023 (H.R. 1262 and S. 542).

Duration: to

General Issues: Health Issues, Natural Resources

Spending: about $2,090,000 (But it's complicated. Here's why.)

Agencies lobbied since 2012: U.S. Senate, House of Representatives, Internal Revenue Service (IRS), Natl Economic Council (NEC), Treasury - Dept of, White House Office, Homeland Security - Dept of (DHS), General Services Administration (GSA), Interior - Dept of (DOI), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Office of the Vice President of the United States, Agriculture - Dept of (USDA)

Affiliated organizations: Air Products & Chemicals, Inc.; AirGas, Inc; American Air Liquide Holdings, Inc.; Catalina Cylinders; Chart Industries, Inc.; Ikaria, Inc.; Linde North America, Inc.; Luxfer Gas Cylinders USA; Matheson; NuCO2 Inc.; Praxair, Inc; Roberts Oxygen Company, Inc.; Taylor-Wharton Intl/Sherwood Valve

Related Foreign Entities: Linde AG (80331 Munich, GER); contribution to lobbying: $100; ownership 100%

Bills mentioned

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.1262: CCU Parity Act of 2023

Sponsor: David Schweikert (R-Ariz.)

S.542: CCU Parity Act of 2023

Sponsor: Sheldon Whitehouse (D-R.I.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Michael Tiller n/a
Richard Gottwald n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page